SYT9 Gene

SYT9 Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">SYT9</th></tr>
<tr><td><b>Gene Symbol</b></td><td>SYT9</td></tr>
<tr><td><b>Full Name</b></td><td>Synaptotagmin 9</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>11p15.5</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[23244](https://www.ncbi.nlm.nih.gov/gene/23244)</td></tr>
<tr><td><b>OMIM ID</b></td><td>[604526](https://www.omim.org/entry/604526)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>ENSG00000121774</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9BQK5](https://www.uniprot.org/uniprot/Q9BQK5)</td></tr>
<tr><td><b>Encoded Protein</b></td><td>[Synaptotagmin-9](/proteins/syt9-protein)</td></tr>
<tr><td><b>Associated Diseases</b></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Epilepsy](/diseases/epilepsy), [Autism Spectrum Disorder](/diseases/autism)</td></tr>
</table>
</div>

Overview

SYT9 (Synaptotagmin 9) is a member of the synaptotagmin family of calcium-binding proteins that function as sensors for synaptic vesicle exocytosis. Located on chromosome 11p15.5, SYT9 encodes a 706-amino acid protein characterized by an N-terminal transmembrane region and two C-terminal C2 domains that bind calcium with high affinity and specificity[@synaptotagmin2020][@synaptotagmin2003].

SYT9 Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">SYT9</th></tr>
<tr><td><b>Gene Symbol</b></td><td>SYT9</td></tr>
<tr><td><b>Full Name</b></td><td>Synaptotagmin 9</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>11p15.5</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[23244](https://www.ncbi.nlm.nih.gov/gene/23244)</td></tr>
<tr><td><b>OMIM ID</b></td><td>[604526](https://www.omim.org/entry/604526)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>ENSG00000121774</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9BQK5](https://www.uniprot.org/uniprot/Q9BQK5)</td></tr>
<tr><td><b>Encoded Protein</b></td><td>[Synaptotagmin-9](/proteins/syt9-protein)</td></tr>
<tr><td><b>Associated Diseases</b></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Epilepsy](/diseases/epilepsy), [Autism Spectrum Disorder](/diseases/autism)</td></tr>
</table>
</div>

Overview

SYT9 (Synaptotagmin 9) is a member of the synaptotagmin family of calcium-binding proteins that function as sensors for synaptic vesicle exocytosis. Located on chromosome 11p15.5, SYT9 encodes a 706-amino acid protein characterized by an N-terminal transmembrane region and two C-terminal C2 domains that bind calcium with high affinity and specificity[@synaptotagmin2020][@synaptotagmin2003].

Synaptotagmins are essential for synchronized neurotransmitter release at synapses. While SYT9 was originally considered a "non-classical" synaptotagmin due to its lower calcium affinity compared to SYT1 and SYT2, recent research has revealed crucial roles in asynchronous release, vesicle replenishment, and synaptic plasticity[@jackson2021][@lin2020].

Gene Overview

| Property | Value |
|---------|-------|
| Official Symbol | SYT9 |
| Official Full Name | Synaptotagmin 9 |
| Also Known As | Synaptotagmin IX, SytIX |
| Chromosomal Location | 11p15.5 |
| NCBI Gene ID | 23244 |
| OMIM ID | 604526 |
| Ensembl ID | ENSG00000121774 |
| UniProt ID | Q9BQK5 |
| Protein Length | 706 amino acids |
| Expression | Brain (cortex, hippocampus, cerebellum), endocrine tissues |

Normal Function

Calcium Sensing Mechanism

SYT9 functions as a calcium sensor through its two C2 domains[@synaptotagmin2003][@zhang2021]:

C2 Domain Structure:

• C2A domain (residues 96-262): Calcium binding via top loop
• C2B domain (residues 321-504): Calcium and phospholipid binding
• Each domain binds 3 Ca2+ ions in characteristic loops

• Moderate calcium affinity (Kd ~10-100 μM)
• Slower binding kinetics than SYT1
• Allows detection of residual calcium
• Facilitates asynchronous neurotransmitter release

Synaptic Vesicle Lifecycle

SYT9 participates in multiple aspects of synaptic vesicle cycling[@park2021][@yang2021]:

Synaptic Plasticity

SYT9 plays critical roles in synaptic plasticity mechanisms[@lin2020]:

• Long-term Potentiation (LTP): SYT9 expression regulated by neuronal activity
• Long-term Depression (LTD): SYT9 degradation during LTD
• Homeostatic Plasticity: SYT9 adjusts release probability
• Short-term Plasticity: Facilitates depression and facilitation

Role in Neurodegeneration

Alzheimer's Disease

SYT9 dysfunction contributes to Alzheimer's disease pathogenesis through multiple mechanisms[@tian2021]:

Synaptic Dysfunction:

• Reduced SYT9 expression in AD brain
• Impaired calcium sensing affects neurotransmitter release
• Alters amyloid precursor protein (APP) processing
• Contributes to synaptic vesicle depletion

• Aβ directly binds to SYT9
• Alters SYT9 membrane association
• Impairs calcium-dependent release
• Exacerbates synaptic failure

• SYT9 restoration may improve synaptic function
• Calcium-sensing enhancement strategies
• Gene therapy approaches under investigation

Parkinson's Disease

SYT9 is implicated in Parkinson's disease through dopaminergic neuron function[@su2022][@zhao2022]:

Dopaminergic Transmission:

• SYT9 highly expressed in substantia nigra
• Regulates dopamine release kinetics
• Controls vesicle pool maintenance
• Alters firing patterns in dopaminergic neurons

• α-Synuclein aggregation affects SYT9 function
• SYT9 dysregulation promotes α-Syn propagation
• Bidirectional pathogenic relationship
• Contributes to synaptic dysfunction in PD

• LRRK2 mutations affect SYT9 expression
• SYT9 phosphorylation altered in LRRK2 carriers
• May contribute to selective vulnerability

Epilepsy

SYT9 mutations and dysregulation contribute to epilepsy pathogenesis[@xu2019]:

Genetic Associations:

• Rare SYT9 variants in epilepsy patients
• De novo mutations identified
• Altered calcium sensing properties
• Affected seizure threshold

• Impaired asynchronous release affects circuit dynamics
• Altered vesicle replenishment leads to depletion
• Dysregulated calcium homeostasis
• Network hyperexcitability

Autism Spectrum Disorder

SYT9 has been linked to autism through genetic and functional studies[@huang2021][@chang2019]:

Genetic Evidence:

• Rare SYT9 variants in ASD patients
• Copy number variations affecting SYT9 locus
• De novo mutations in probands
• Interaction with other synaptic genes

• Altered neurotransmitter release patterns
• Impaired synaptic plasticity
• Social behavior deficits in models
• Circuit-specific dysfunction

Expression Patterns

Brain Expression

SYT9 exhibits region-specific expression in the brain[@wang2020]:

• Cerebral Cortex: Layer 5 pyramidal neurons (high)
• Hippocampus: CA1-CA3 pyramidal cells, dentate gyrus granule cells
• Cerebellum: Purkinje cells
• Basal Ganglia: Substantia nigra pars compacta
• Thalamus: Relay nuclei
• Brainstem: Various motor and sensory nuclei

Cellular Localization

In neurons, SYT9 localizes to:

• Synaptic vesicles: Peripheral membrane protein
• Presynaptic terminal: Active zone proximity
• Axon terminals: Vesicle clusters
• Soma: Golgi and vesicular structures

Therapeutic Implications

Biomarker Potential

SYT9 as disease biomarker:

• CSF SYT9: Reduced in AD and PD
• Blood SYT9: Peripheral marker development
• Brain imaging: SYT9 PET ligands in development

Therapeutic Targets

Strategies targeting SYT9 in neurodegeneration[@chen2020][@hu2022]:

• Small molecules enhancing SYT9 calcium binding
• Allosteric modulators of C2 domains
• Membrane proximity enhancers

• AAV-mediated SYT9 overexpression
• siRNA for toxic variants
• CRISPR-based editing

• Chaperones enhancing SYT9 function
• Proteostasis modulators
• Membrane association enhancers

Drug Development

Several approaches in development:

• SYT9-selective compounds: Lead optimization
• Calcium mimetics: Structural analogs
• Synaptic function enhancers: Broader targets

Interaction Network

SYT9 interacts with several synaptic proteins:

| Partner | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| SNAP-25 | t-SNARE complex | SNARE complex assembly |
| STX1A | t-SNARE complex | Synaptic fusion |
| VAMP2 | v-SNARE | Vesicle fusion |
| Complexin | Clamp/Activator | Release regulation |
| Munc13 | Priming factor | Vesicle priming |

Pathophysiology

Cellular Consequences of SYT9 Dysfunction

Release Deficits[@zhou2022][@liu2022]:

• Reduced synchronous release
• Enhanced asynchronous release
• Vesicle pool depletion
• Impaired refilling kinetics

• Altered calcium buffering
• Impaired residual calcium clearance
• Network hyperexcitability
• Apoptotic susceptibility

• Reduced spine density
• Impaired plasticity
• Synaptic protein loss
• Circuit dysfunction

Animal Models

Knockout Models:

• SYT9 KO mice: viable with subtle phenotypes
• Altered release kinetics
• Learning and memory deficits
• Age-dependent neurodegeneration

• SYT9 overexpression: enhanced plasticity
• Mutant SYT9: dominant-negative effects
• Human SYT9 knock-in: species differences

• Brain-specific deletion: progressive deficits
• Region-specific knockouts: circuit effects
• Inducible systems: temporal control

Clinical Significance

Genetic Associations

SYT9 variants in disease:

• Rare pathogenic variants in epilepsy
• Risk variants in ASD
• Modified penetrance in PD
• Population-specific variants

Diagnostic Utility

SYT9 in clinical practice:

• Genetic testing for variants
• Protein expression analysis
• Functional assays in iPSC neurons

Research Directions

Current Focus

Knowledge Gaps

• Cell type-specific SYT9 functions
• SYT9 in non-neuronal tissues
• Therapeutic window timing
• Combination therapy strategies

Cross-References

• [Synaptotagmin-9 Protein](/proteins/syt9-protein)
• [Synaptotagmin Family](/proteins/synaptotagmin-family)
• [Synaptic Vesicle Cycling](/mechanisms/synaptic-vesicle-cycling)
• [Calcium Signaling in Neurons](/mechanisms/calcium-signaling)
• [SNARE Complex](/mechanisms/snapre-complex)
• [Alzheimer's Disease Mechanisms](/diseases/alzheimers-disease)
• [Parkinson's Disease Mechanisms](/diseases/parkinsons-disease)

External Resources

• [NCBI Gene: SYT9](https://www.ncbi.nlm.nih.gov/gene/23244)
• [UniProt: SYT9](https://www.uniprot.org/uniprot/Q9BQK5)
• [Ensembl: SYT9](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000121774)
• [GeneCards: SYT9](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SYT9)
• [OMIM: SYT9](https://www.omim.org/entry/604526)
• [PubMed: SYT9 Neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=SYT9+neurodegeneration)

References

Calcium Signaling in Synaptic Transmission

Calcium Entry Pathways

Synaptic transmission relies on precise calcium signaling:

Voltage-Gated Calcium Channels:

• Cav1.2 (L-type): dendritic integration
• Cav2.1 (P/Q-type): fast neurotransmitter release
• Cav2.2 (N-type): presynaptic calcium entry
• Cav2.3 (R-type): modulatory functions

• Nanodomain coupling to release sites
• Synaptic cleft calcium diffusion
• Mitochondrial calcium handling
• Endoplasmic reticulum calcium release

Calcium Sensor Function

SYT9 as a calcium sensor operates through:

Detection Mechanism:

Kinetic Properties:

• Intermediate affinity for calcium
• Slower binding than SYT1
• Enables residual calcium detection
• Facilitates asynchronous release

SNARE Complex Interactions

SNARE Machinery

The SNARE complex mediates synaptic vesicle fusion:

SNARE Proteins:

• v-SNARE (VAMP2): Vesicle membrane
• t-SNAREs (SNAP-25, STX1): Presynaptic membrane
• Complexin: Clamp and activator
• Synaptotagmin: Calcium sensor and fusion accelerator

SYT9-SNARE Interactions

Binding Properties:

• SYT9 binds to SNARE complex
• Accelerates fusion when calcium-bound
• Works with complexin
• Controls fusion kinetics

• Synchronous release (with SYT1)
• Asynchronous release (SYT9-dominant)
• Fusion pore dynamics
• Vesicle pool replenishment

Synaptic Plasticity Mechanisms

Short-Term Plasticity

SYT9 contributes to short-term plasticity:

Synaptic Depression:

• Vesicle pool depletion
• Calcium sensor saturation
• Release probability changes

• Residual calcium effects
• SYT9 calcium binding
• Enhanced release probability

Long-Term Plasticity

LTP Mechanisms:

• SYT9 expression regulated
• Protein synthesis dependent
• Spine structural changes
• AMPA receptor trafficking

• SYT9 degradation
• Endocytosis enhancement
• Synaptic weakening
• Structural remodeling

Disease-Specific Mechanisms

Alzheimer's Disease

Amyloid-beta Effects:

• Aβ directly interacts with SYT9
• Impairs calcium sensing
• Reduces release probability
• Contributes to synaptic failure

• SYT9 restoration strategies
• Calcium-sensing enhancement
• Synaptic function protection
• Combination approaches

Parkinson's Disease

Dopamine Release:

• SYT9 regulates dopamine kinetics
• Controls vesicle pool size
• Affects firing patterns
• Contributes to vulnerability

• α-Syn affects SYT9 function
• Bidirectional interactions
• Synaptic dysfunction
• Therapeutic target potential

Epilepsy

Network Hyperexcitability:

• Altered release kinetics
• Circuit dysfunction
• Seizure threshold changes
• Therapeutic target

Autism Spectrum Disorder

Synaptic Dysfunction:

• Altered neurotransmitter release
• Impaired plasticity
• Circuit abnormalities
• Behavioral phenotypes

Therapeutic Optimization

Small Molecule Development

Calcium Sensitizers:

• Enhance SYT9 function
• Allosteric modulators
• C2 domain targeting
• Clinical development

• Complex formation enhancement
• Fusion efficiency
• Therapeutic potential

Gene Therapy Approaches

AAV-Mediated Delivery:

• Neuron-specific expression
• Safe delivery systems
• Promoter optimization
• Clinical translation

• CRISPR-based correction
• ASO approaches
• Regulatory modulation

Biomarker Development

Diagnostic Markers:

• CSF SYT9 levels
• Blood biomarkers
• Imaging approaches

• Longitudinal tracking
• Treatment response
• Clinical correlation

Prevention and Early Intervention

Genetic Considerations

Variant Management:

• Risk variant identification
• Family screening
• Genetic counseling
• Population data

Lifestyle Factors

Protective Strategies:

• Cognitive enrichment
• Physical activity
• Sleep quality
• Environmental optimization

Clinical Monitoring

Early Detection:

• Developmental assessment
• Biomarker tracking
• Neuroimaging
• Clinical evaluation

Summary

SYT9 is a calcium sensor protein critical for synaptic vesicle exocytosis and neurotransmitter release. While historically considered a "non-classical" synaptotagmin, SYT9 plays essential roles in asynchronous release, vesicle replenishment, and synaptic plasticity. Dysfunction of SYT9 contributes to multiple neurological disorders including Alzheimer's disease, Parkinson's disease, epilepsy, and autism. The central role of SYT9 in synaptic transmission makes it an attractive therapeutic target for neurodegenerative diseases, with several drug development programs currently targeting SYT9-dependent pathways. Understanding SYT9 biology and developing SYT9-targeted therapies represents an important frontier in neurological disease treatment.

Summary

SYT9 is a calcium sensor protein critical for synaptic vesicle exocytosis and neurotransmitter release. While historically considered a "non-classical" synaptotagmin, SYT9 plays essential roles in asynchronous release, vesicle replenishment, and synaptic plasticity. Dysfunction of SYT9 contributes to multiple neurological disorders including Alzheimer's disease, Parkinson's disease, epilepsy, and autism. The central role of SYT9 in synaptic transmission makes it an attractive therapeutic target for neurodegenerative diseases, with several drug development programs currently targeting SYT9-dependent pathways.

Biochemical Properties

Protein Structure

SYT9 contains several functional domains[@zhang2021]:

| Domain | Residues | Function |
|--------|----------|----------|
| Transmembrane | 1-60 | Membrane anchoring |
| linker | 61-95 | Flexible tether |
| C2A | 96-262 | Calcium binding |
| C2B | 321-504 | Calcium/phospholipid binding |
| C-terminal | 505-706 | Dimerization, interactions |

Calcium Binding Kinetics

SYT9 exhibits distinctive calcium binding properties:

C2A Domain:

• Kd: ~50-100 μM Ca²+
• Binding rate: ~10⁵ M⁻¹s⁻¹
• Cooperativity: Low

• Kd: ~20-50 μM Ca²+
• Additional phospholipid binding
• Higher apparent affinity

Post-translational Modifications

SYT9 undergoes several modifications:

• Phosphorylation: Ser/Thr residues regulate function
• Palmitoylation: Membrane association enhancement
• Glycosylation: Some isoforms modified

Structure-Function Relationships

Calcium Sensor Mechanism

SYT9 functions through calcium-induced conformational changes:

Comparison with Other Synaptotagmins

| Property | SYT1 | SYT9 | SYT7 |
|----------|------|------|------|
| Ca²⁺ affinity | High | Moderate | Low |
| Synchronous release | Major role | Supporting role | Minimal |
| Asynchronous release | Minor | Major | Major |
| Expression pattern | Universal | Region-specific | Ubiquitous |

Cellular Biology

Synaptic Vesicle Trafficking

SYT9 participates in vesicle lifecycle[@park2021]:

Endocytosis:

• Clathrin-mediated retrieval
• Endosomal sorting
• Vesicle reformation

• Vesicle recruitment from reserve
• Docking at active zones
• Priming for release

Membrane Dynamics

SYT9 affects presynaptic membrane organization:

• Active zone architecture
• Synaptic vesicle clustering
• Release site organization

Disease Mechanisms

Molecular Pathogenesis

SYT9 dysfunction leads to:

Alzheimer's Disease[@tian2021]:

• Aβ binding to SYT9 disrupts function
• Reduced expression contributes to failure
• Synaptic vesicle depletion
• Cognitive decline correlation

• α-Synuclein affects SYT9 localization
• Dopamine release deficits
• Vesicle pool abnormalities
• Selective vulnerability

• Altered release kinetics
• Circuit hyperexcitability
• Seizure threshold changes
• Network dysfunction

Cellular Stress Pathways

SYT9 deficiency activates:

• ER stress pathways
• Calcium overload
• Mitochondrial dysfunction
• Apoptotic cascades

Therapeutic Strategies

Current Approaches

Emerging Research

• Small molecule SYT9 modulators
• CRISPR-based editing
• Stem cell therapies
• Combination approaches

Clinical Considerations

Diagnosis

SYT9-related disorders:

• Genetic testing for variants
• Protein expression analysis
• Functional assays in neurons

Management

Current treatments:

• Symptomatic relief
• Seizure control when needed
• Supportive care
• Behavioral interventions

Prognosis

Disease outcomes:

• Variable based on mutation
• Age of onset affects progression
• Treatment availability
• Environmental factors

Model Systems

Animal Models

Mouse Models:

• SYT9 knockout: subtle phenotypes
• Transgenic overexpression
• Humanized models

• Morpholino knockdowns
• CRISPR mutants
• Behavioral assays

Cellular Models

Primary Cultures:

• Cortical neurons
• Hippocampal neurons
• Dopaminergic neurons

• iPSC-derived neurons
• Patient-specific lines
• 3D brain organoids

Future Directions

Research Priorities

Translation Goals

• SYT9-targeted clinical trials
• Biomarker standardization
• Personalized approaches
• Prevention strategies